**Executive Summary**
The Indian Pharmacopoeia Commission (IPC) signed three Memoranda of Understanding (MoUs) on February 9, 2026, with the Goa State Pharmacy Council (GSPC), Quality Council of India (QCI), and HLL Infra Tech Services Limited (HITES). The MoUs aim to strengthen medicine safety, quality standards, and capacity building in India. The goal is to promote patient safety and quality healthcare delivery.
**Key Points / Main Content**
* **General Overview:**
* The IPC, under the Ministry of Health and Family Welfare, has entered into three MoUs to enhance drug safety, quality assurance, and capacity-building initiatives.
* **MoU with Goa State Pharmacy Council (GSPC):**
* Provides a framework for collaboration in pharmacovigilance, rational medicine use, and professional development of pharmacists in Goa.
* Aims to promote the National Formulary of India among registered pharmacists.
* Strengthens adverse drug reaction (ADR) reporting mechanisms under the Pharmacovigilance Programme of India (PvPI).
* Includes conducting training programmes, workshops, continuing education, and awareness initiatives related to drug safety and pharmacopoeial standards.
* Supports establishing and strengthening ADR Monitoring Centres.
* Enhances systematic reporting and documentation practices in healthcare facilities in Goa.
* **MoU with Quality Council of India (QCI):**
* Focuses on quality promotion, public health awareness, and capacity building.
* Includes joint planning and implementation of training and awareness programmes.
* Utilizes institutional expertise and technical resources.
* Develops collaborative initiatives aligned with national quality and safety objectives.
* Provides a flexible, non-binding framework for project-based cooperation through mutually agreed work orders.
* Supports quality assurance and standardisation in the healthcare sector.
* **Overall Objectives:**
* Foster institutional partnerships with regulatory bodies, professional councils, quality organizations, and public sector enterprises.
* Strengthen pharmacovigilance systems.
* Enhance professional competencies.
* Promote uniform standards for medicine quality and patient safety across the country.
**Impact Analysis**
**Goa State Pharmacy Council (GSPC):**
**Impact**
* Enhanced collaboration with IPC for pharmacovigilance and pharmacist development.
**Action Required**
* Participate in joint initiatives and training programs.
**Quality Council of India (QCI):**
**Impact**
* Collaboration with IPC on quality promotion and public health awareness.
**Action Required**
* Engage in joint planning and implementation of training and awareness programs.
**Pharmacists/Healthcare Professionals:**
**Impact**
* Increased opportunities for training, continuing education, and professional development,
* Enhanced awareness of drug safety and pharmacopoeial standards.
**Action Required**
* Participate in training programs and promote the National Formulary of India.
**Patients:**
**Impact**
* Improved medicine safety and quality healthcare delivery.
**Action Required**
* None specified.
**Ministry of Health and Family Welfare:**
**Impact**
* Strengthening of regulatory and professional collaboration.
**Action Required**
* Sustained efforts required to achieve long-term public health goals.
Key Entities Referenced
Indian Pharmacopoeia Commission (IPC): Autonomous institution focused on setting drug standards, that signed MoUs to bolster medicine safety and quality.
Ministry of Health and Family Welfare: The ministry under which the IPC functions and which oversees the MoUs related to medicine safety and quality standards.
Pharmacovigilance Programme of India (PvPI): Program aiming to strengthen adverse drug reaction (ADR) reporting mechanisms.
Quality Council of India (QCI): Organization that signed an MoU with the IPC to drive healthcare quality promotion, public awareness, and capacity building.
Goa: State in which the Goa State Pharmacy Council (GSPC) MoU with the IPC aims to strengthen pharmacist training and drug safety systems.
Ministry of Health and Family Welfare
Indian Pharmacopoeia Commission Signs Three
MoUs to Bolster Medicine Safety, Quality
Standards, and Capacity Building
IPC–Goa State Pharmacy Council (GSPC) MoU to Enhance
Pharmacovigilance, Promote Rational Medicine Use, and
Strengthen Pharmacist Training and Drug Safety Systems in
Goa
IPC– Quality Council of India (QCI) MoU to Drive Healthcare
Quality Promotion, Public Awareness, and Capacity Building
through Joint Initiatives
Posted On: 09 FEB 2026 4:22PM by PIB Delhi
The Indian Pharmacopoeia Commission (IPC), an autonomous institution under the Ministry of Health
and Family Welfare, Government of India, has entered into Memoranda of Understanding (MoUs) with
the Goa State Pharmacy Council (GSPC), Quality Council of India (QCI), and HLL Infra Tech Services
Limited (HITES), to strengthen drug safety, quality assurance, and capacity-building initiatives in the
country.The MoU between IPC and GSPC provides a structured framework for collaboration in the areas of
pharmacovigilance, rational use of medicines, and professional development of pharmacists in the State of
Goa. The collaboration envisages promotion of the National Formulary of India among registered
pharmacists, strengthening of adverse drug reaction (ADR) reporting mechanisms under the
Pharmacovigilance Programme of India (PvPI), conduct of training programmes, workshops, and
continuing education activities, and facilitation of awareness initiatives related to drug safety,
pharmacopoeial standards, and sustainable pharmacopoeia. The MoU also aims to support the
establishment and strengthening of ADR Monitoring Centres and enhance systematic reporting and
documentation practices across healthcare facilities in the state.
Under the MoU signed between IPC and QCI, both institutions have agreed to collaborate in areas of
mutual interest relating to quality promotion, public health awareness, and capacity building. The
cooperation includes joint planning and implementation of training and awareness programmes,
particularly in relation to pharmacovigilance and allied subjects, utilisation of institutional expertise and
technical resources, and development of collaborative initiatives aligned with national quality and safety
objectives. The MoU is intended to provide a flexible, non-binding framework to facilitate project-based
cooperation, with specific activities to be undertaken through mutually agreed work orders, while
supporting the broader mandate of quality assurance and standardisation in the healthcare sector.
IPC is continuing efforts to foster institutional partnerships with regulatory bodies, professional councils,
quality organisations, and public sector enterprises with a view to strengthening pharmacovigilance
systems, enhancing professional competencies, and promoting uniform standards for medicine quality and
patient safety across the country.
The Joint Secretary, Ministry of Health and Family Welfare (MoHFW), Shri Harsh Mangla, emphasized
the critical role of the regulatory sector in the effective implementation of primary and secondary
healthcare across the country. Shri Mangla congratulated Dr. V. Kalaiselvan, Secretary-cum-Scientific
Director (IPC), and the representatives of the Goa State Pharmacy Council and NABET, QCI, addressing
the gathering on the occasion of the MoU signing. He described the MoU as a significant starting point for
institutional partnership, while underscoring that sustained efforts would be required to achieve long-term
public health goals.Shri Mangla further highlighted that MoUs should not remain symbolic in nature, but must translate into
the achievement of objectives in their true sense. He noted that IPC has signed four MoUs in the past,
reflecting its continued commitment to strengthening regulatory and professional collaboration.
Shri Mangla further stressed that drugs and pharmaceuticals deserve the highest level of attention and that
enhancing awareness among pharmacists is crucial for ensuring patient safety and quality healthcare
delivery. He highlighted the Government of India’s continued efforts to strengthen and flourish the
pharmaceutical and healthcare sector through policy support, regulatory reforms, and capacity-building
initiatives. He added that the MoUs would play a key role in training, capacity building, and continuing
professional education of pharmacists, thereby contributing to the overall improvement of public health
outcomes.
****
SR
HFW/IPC signs 3 MoUs/9th February 2026/1
(Release ID: 2225435) Visitor Counter : 332
Read this release in: Urdu , ही